Retrospective Study on the WalkOn AFO in Children or Teenagers with Neurological Pathologies

Launched by OTTO BOCK FRANCE SNC · Dec 13, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a special device called the WalkOn ankle-foot orthosis (AFO) is for helping children and teenagers who have trouble walking due to conditions like cerebral palsy, spinal cord injuries, or other neurological issues. The study aims to find out if using this carbon fiber AFO can improve their walking ability and if those who use it are happy with the results. Researchers will examine data from patients who have already tried the AFO and had their walking patterns assessed both with and without it.

To be eligible for this study, participants must be children or teenagers whose walking is affected by certain motor impairments and have already tested out the WalkOn AFO in the last three years. They also need to have a previous walking assessment recorded in their medical files. If families choose to participate, they can expect to contribute valuable information that may help improve treatments for kids with similar conditions. It's important to note that participation is voluntary, and families can choose not to take part or can withdraw at any time without any consequences.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient, child or adolescent, whose gait is affected by central or peripheral motor impairments
• • Patient who has carried out a one-off trial of a WalkOn AFO (Ankle-Foot Orthosis) within the last 3 years prior to the beginning of the study (inclusion period)
• • Patient whose quantified gait analysis with the WalkOn AFO and without orthosis is available in the medical file and whose date is within the inclusion period
• • The investigator has verified that the patient and the parental authorities have received the information note concerning the study
• • The investigator has verified that the person and the parental authorities do not object to the processing of data necessary for the study
• Exclusion Criteria:
• • • Patients or holders of parental authority objecting to the processing of data within the framework of the study